Target intelligence / Profile preview

Crotalid venom toxins

Molecular classification
Enzyme, Phospholipase A2, Snake venom metalloproteinase, Snake venom serine protease, C-type lectin, Disintegrin
01

Overview

Homologous toxins in other crotalid venoms refers to a group of structurally and functionally related proteins found in the venom of snakes within the Crotalinae subfamily, such as rattlesnakes, copperheads, and cottonmouths. These toxins primarily include phospholipase A2 (PLA2) enzymes, snake venom metalloproteinases (SVMPs), and serine proteases, which are responsible for the diverse clinical manifestations of snakebite envenomation (PMID: 30114438). They function by disrupting physiological processes, leading to symptoms such as systemic coagulopathy, local tissue necrosis, and neurotoxicity (PMID: 31603345). In the pharmaceutical industry, these toxins are the primary targets for polyvalent antivenoms, which utilize purified antibodies or antibody fragments to bind and neutralize the venom components (PMID: 22403236). The homology between these toxins across different species allows for the development of antivenoms with broad-spectrum efficacy against multiple snake types. Additionally, specific toxin families like PLA2 are being investigated as targets for small-molecule inhibitors like varespladib to provide rapid, field-deployable treatment options (PMID: 27383360). Understanding the molecular evolution and conservation of these toxins is essential for improving the potency and safety of modern snakebite therapeutics.

Other names
Pit viper venom proteinsCrotalinae toxinsCrotalid venom componentsHomologous crotalid toxins
02

Mechanism of action

Antivenoms act by binding to the venom toxins, forming immune complexes that prevent the toxins from interacting with their biological targets and facilitating their clearance from the body (PMID: 22403236). Small molecule inhibitors like varespladib target the active site of phospholipase A2 enzymes to competitively inhibit their catalytic activity (PMID: 27383360).

03

Biological functions

ProteolysisHemolysisNeurotoxicityMyotoxicityPlatelet aggregation inhibitionAnticoagulation
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageLocal tissue necrosisNeurotoxicity
05

Safety considerations

AnaphylaxisSerum sicknessHypersensitivity reactionsAntivenom-induced thrombocytopenia
06

Interacting drugs

Crotalidae Polyvalent Immune Fab (Ovine)

2 more in the full profile.

07

Biomarkers

Fibrinogen levelPlatelet countProthrombin timeCreatine kinase

Beyond the preview

Go deeper on Crotalid venom toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crotalid venom toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call